In addition, APOBEC3B can also be considered a potential target for therapeutic intervention since the inhibition of APOBEC3B catalytic activity has shown a decrease in the rate of tumor mutation and thereby diminishes the chances of unwanted mutation-related consequences, namely metastasis, recurrence, and the occurrence of therapy resistive cancer types [83,84]. Here, APOBEC3B is linked to cancer.